[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551336":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":10,"centralContacts":10,"locations":21,"responsibleParty":42,"collaborators":10,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":60,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Candiolo Cancer Institute - IRCCS","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Patients",null,[12],"Other: Questionnaire",{"label":14,"type":10,"description":10,"interventionNames":15},"Controls",[12],[17],{"type":6,"name":18,"description":19,"armGroupLabels":20,"otherNames":10},"Questionnaire","none, it's a incidence-prevalence study",[14,9],[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"IRCCS Candiolo Cancer Center","RECRUITING","Torino","TO","10060","Italy","IT",{"type":31,"coordinates":32},"Point",[33,34],11.99138,44.88856,{"lat":34,"lon":33},[37],{"name":38,"role":39,"phone":40,"phoneExt":10,"email":41},"Giada Pozzi, MD","CONTACT","+390119933017","giada.pozzi@ircc.it",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Giada Pozzi","MD","100551336","sexual-dysfunction-check-up-in-premenopausal-breast-cancer-survivors-taking-endocrine-therapy-a-cross-sectional-study-100551336",false,"NCT06458764","Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study","SEXCHECK - Sexual Dysfunction Check-up in Premenopausal Breast Cancer Survivors Taking Endocrine Therapy: A Cross-Sectional Study","SEXCHECK","Inclusion Criteria:\n\n* women aged ≥18 and ≤ 55\n* who underwent surgery for early stage breast cancer\n* taking endocrine therapy for at least 3 months\n* providing an informed consent and completing the study questionnaires.\n\nExclusion Criteria:\n\n* withdrawal of the informed consent, at any time","FEMALE","18 Years","55 Years",{"count":58,"type":59},150,"ESTIMATED","1 Month","OBSERVATIONAL","Primary objectives:\n\n* To estimate Sexual Dysfunction (SD) incidence in premenopausal breast cancer patients treated by surgery and taking endocrine therapy.\n* To detect the presence of SD-related distress in the population, as a determining factor in the maintenance of a good quality of life.\n\nSecondary objectives:\n\n* To describe SD characteristics determining the most frequently reported symptoms and correlations with type of surgery or therapeutic regimens.\n* Collect baseline data for subsequent randomized trials involving practical interventions with the aim to reduce SD prevalence in this population.",[64,65,66],"Breast Cancer Female","Sexual Dysfunction","Premenopausal Breast Cancer","2025-06-18",{"date":69,"type":70},"2025-06-24","ACTUAL",{"date":72,"type":70},"2023-05-01",{"date":74,"type":59},"2025-12-01",{"name":5,"class":6},1]